Does transplantation of parthenogenetic embryonic stem cells ameliorate cardiac dysfunction and remodelling after myocardial infarction?
Transplantation of pESCs could attenuate cardiac dysfunction and adverse ventricular remodelling post-MI, suggesting that pESCs may provide promising therapeutic sources for MI in females.
Higher levels of serum adiponectin, leptin and LAR were positively associated with CKD independent of traditional risk factors in this Asian population.